Approximately three weeks ago she started having a red spot in her right eye.
Denies current floaters, scotoma, other visual changes  Past Medical History: hypertension hyperglycemia, hgbA1c 7.1 - no prior h/ DM s/p finger surgery s/p skin biopsy   Social History: Lives with her son.
Family History: no known leukemia, lymphoma or cancer; father with CVA, [**1-22**] sister with DM; does not know maternal history; 2 healthy sons and one healthy gransdson  Physical Exam: Admission Physical Exam: VS: 144/80 85 RR 18 95%/ra General: well, NAD HEENT: MMM, PERRLA, EOMI, no jaundice, sclera normal Neck: supple Heart: RRR no R/G/M Lungs: clear Abdomen: soft, nontender, +bs, splenomegaly extending down to umbilicus Extremities: no edema, 2+ distal pulses Neuro: CN2-12 intact, strength and sensation intact across upper and lower extremities  Discharge Physical Exam: No significant change  Pertinent Results: Admission Labs [**2170-5-15**] 08:40PM: WBC-385.9* RBC-3.47* Hgb-9.0* Hct-27.0* MCV-84 MCH-25.7* MCHC-30.7* RDW-16.1* Plt Ct-125* Neuts-2* Bands-0 Lymphs-87* Monos-1* Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 Blasts-0 Other-10* PT-12.3 PTT-30.7 INR(PT)-1.1 Glucose-162* UreaN-17 Creat-0.7 Na-140 K-3.9 Cl-104 HCO3-27 AnGap-13 ALT-16 AST-45* LD(LDH)-503* AlkPhos-175* TotBili-0.4 Albumin-4.7 Calcium-9.0 Phos-4.0 Mg-2.3 UricAcd-6.7* Iron-52 calTIBC-391 Ferritn-88 TRF-301 IgG-934 IgA-49* IgM-83  CT head without contrast [**2170-5-15**]:  No evidence of acute intracranial process.
Prominent lymph nodes, partially imaged, for which clinical correlation is recommended.
While awaiting results of the bone marrow biopsy, the patient was started on hydoxyurea.
She was also started on allopurinol for prophylaxis.
She underwent her first cycle of IV bendamustine while in house without signficant side effects.
# Visual Changes: Red spot in right eye 3 weeks prior to admission suggestive of a retinal hemorrhage which has now resolved.
She underwent leukophoresis for presumed leukostasis retinopathy, as above.
She was treated with hydroxyurea and prednisone before ultimately starting her first cycle of bendamustine.
She was restarted on home regimen on discharge.
The patient was started on QAHCS with HISS.
With initiation of prednisone for leukostasis retinopathy, she began to require insulin sliding scale.
TRANSITIONAL ISSUES - Monitor blood sugar and consider initation of blood sugar lowering agents - Continue to monitor blood counts as outpatient - Complete treatment course of rituxan/bendamustine as per outpatient recommendations  Medications on Admission: HCTZ 12.5mg enalapril 5mg or 10mg (she is unsure) calcium  Discharge Medications: 1. hydrochlorothiazide 12.5 mg Tablet Sig: One (1) Tablet PO once a day.
2. enalapril maleate 5 mg Tablet Sig: One (1) Tablet PO once a day.
Discharge Disposition: Home  Discharge Diagnosis: Dear Ms [**Known lastname 110448**], during this admission you have been diagnosed with a condition called Chronic Lymphocytic Leukemia (CLL), you have received treatment with a chemotherapy called bendamustine on day [**5-18**] and [**5-19**].
Discharge Instructions: You can resume your home medications (hydrochlorthiazide and enalapril at the previous dose).
